Sandostatin LAR Depot and Tofacitinib Extended-Release Tablets
Determining the interaction of Sandostatin LAR Depot and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sandostatin LAR Depot-Tofacitinib Tablets
- Sandostatin LAR Depot-Tofranil
- Sandostatin LAR Depot-Tofranil injection
- Sandostatin LAR Depot-Tofranil-PM
- Sandostatin LAR Depot-Tol-Tab
- Sandostatin LAR Depot-Tolazamide
- Tofacitinib Extended-Release Tablets-Sandostatin LAR Depot injection
- Tofacitinib Extended-Release Tablets-Sani-Supp
- Tofacitinib Extended-Release Tablets-Sani-Supp rectal
- Tofacitinib Extended-Release Tablets-Sansert
- Tofacitinib Extended-Release Tablets-Santyl
- Tofacitinib Extended-Release Tablets-Saphris